Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Syneos Health, Inc.
Syneos Health, Inc. News
May 27, 2025 - https://www.prnewswire.com
Real World Evidence (RWE) Oncology Market to Reach $3.51 Billion by 2035, Growing at a CAGR of 14.7% from 2025--Exclusive Report by Meticulous Research®
Mar 25, 2025 - globenewswire.com
SCIENTURE Announces Commercial Operations Leadership and Strategic Agreement with Syneos Health, a leading Contract Sales Organization
Syneos Health, Inc. Quantitative Score
About Syneos Health, Inc.
Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in the Phase I to IV of clinical development. This segment also provides individual services, including product development and regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health, clinical trial diversity, biometric, and regulatory affair services. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, such as public relations, advertising, and medical communication services; and consulting services to the pharmaceutical, biotechnology, and healthcare industries. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina.
Syneos Health, Inc. Earnings & Revenue
What’s This Company Really Worth? Find Out Instantly.
Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.
Syneos Health, Inc. Financials
Table Compare
Compare SYNH metrics with: | |||
|---|---|---|---|
Earnings & Growth | SYNH | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | SYNH | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | SYNH | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | SYNH | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Syneos Health, Inc. Income
Syneos Health, Inc. Balance Sheet
Syneos Health, Inc. Cash Flow
Syneos Health, Inc. Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Buy |
| Return on Equity | Neutral |
| Return on Assets | Buy |
| Debt/Equity Ratio | Strong Buy |
| Price/Earnings Ratio | Strong Buy |
| Price/Book Ratio | Neutral |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Historical Market Cap
Shares Outstanding
Syneos Health, Inc. Executives
| Name | Role |
|---|---|
| Mr. Alistair Macdonald | Advisor |
| Ms. Michelle Keefe | Chief Executive Officer & Director |
| Mr. Michael Lee Brooks | Chief Operating Officer |
| Mr. Jason M. Meggs | Consultant |
| Mr. Jonathan Olefson Esq. | Gen. Counsel & Corporation Sec. |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Mr. Alistair Macdonald | Advisor | Male | 1970 | 1.25M |
| Ms. Michelle Keefe | Chief Executive Officer & Director | Female | 1967 | 876.28K |
| Mr. Michael Lee Brooks | Chief Operating Officer | Male | 1974 | 702.11K |
| Mr. Jason M. Meggs | Consultant | Male | 1976 | 624.83K |
| Mr. Jonathan Olefson Esq. | Gen. Counsel & Corporation Sec. | Male | 1976 | 526.14K |
Syneos Health, Inc. Insider Trades
| Date | 28 Sep |
| Name | Zulueta Alfonso G |
| Role | Director |
| Transaction | Disposed |
| Type | D-Return |
| Shares | 3493 |
| Date | 28 Sep |
| Name | Zulueta Alfonso G |
| Role | Director |
| Transaction | Disposed |
| Type | D-Return |
| Shares | 4863 |
| Date | 28 Sep |
| Name | Wilkes David S. |
| Role | Director |
| Transaction | Disposed |
| Type | D-Return |
| Shares | 4973 |
| Date | 28 Sep |
| Name | Wilkes David S. |
| Role | Director |
| Transaction | Disposed |
| Type | D-Return |
| Shares | 4863 |
| Date | 28 Sep |
| Name | Monaghan Matthew E. |
| Role | Director |
| Transaction | Disposed |
| Type | D-Return |
| Shares | 19777 |
| Date | Name | Role | Transaction | Type | Shares |
|---|---|---|---|---|---|
| 28 Sep | Zulueta Alfonso G | Director | Disposed | D-Return | 3493 |
| 28 Sep | Zulueta Alfonso G | Director | Disposed | D-Return | 4863 |
| 28 Sep | Wilkes David S. | Director | Disposed | D-Return | 4973 |
| 28 Sep | Wilkes David S. | Director | Disposed | D-Return | 4863 |
| 28 Sep | Monaghan Matthew E. | Director | Disposed | D-Return | 19777 |